I am the CEO of CureMyWay, an international consulting firm in the health sector. My approach to projects involves decision science, my PhD in psychology, behavioral economics (I did work at Princeton University with Nobel Prize winner, Daniel Kahneman), and consumer behavior, which I taught at Wharton. I specialize in finding the levers and barriers to driving behavior change.
Among my clients are some of the world’s largest pharmaceutical companies: Pfizer, Abbvie, Merck, Novartis, Johnson & Johnson, alongside BMS, Boringer-Ingleheim, and many others. I have also worked with technological giants, such as NantHealth and Samsung, and with numerous startups, such as Healarium, Glucome, Wisdo (whom I mentored when they were at the Microsoft Ventures accelerator), Telesofia, as well as with many more companies, including health advertisers and PR companies.
As the author of over over 70 academic papers on medical decision-making and related topics, and as a visiting researcher at the University of Cambridge, I have the credentials to work directly with high-powered physicians. I have, for example, led advisory boards on the introduction of new drugs, and spoken at medical meetings on topics such as adherence to medication.
To discuss a potential collaboration, go here.
What people are saying
“[Dr. Miron-Shatz] brought her knowledge of the psychology of patients’ motivations, along with behavioral economics into the product design and requirements. Her contributions were both insightful, and very practical after clearly understanding our product constraints. [She] quickly gained the respect and trust of the product development team and became a key contributor to the product. Her professional skills, human-factors skills and knowledge of behavior modification are a big plus for any product team developing patient-facing solutions.”— Vasu Rangadass, President & CEO at L7 Informatics
My interests are versatile and revolve around decision making. Here are some examples of successful; projects:
- Increasing engagement and retention at a wellness website, employee programs and more. Considerable investment goes into programs and websites, such as around diabetes and wellness. Why then is uptake so low, and why are results so disappointing? I introduced a decision-science-based transformations in the website design, membership tiers, reward structure—the works. The result: increased consumer engagement, as measured by time using the device and number of entries to the website. And, of course, increased revenue and customer satisfaction.
- Creating guidelines for medication adherence. As a decision scientist and an expert on adherence, patient communication, and health literacy, I was hired by a large pharmaceutical brand to create and revise adherence guidelines for increasing patient adherence.
- Changing prescriber behavior. Prescriber behavior is another angle of consumer behavior, except this time the consumers are physicians—educated, well-intentioned, overworked individuals, whose decision making processes are decidedly human. I worked on unveiling physician reasons for prescribing, on physician advisory boards displaying the advantages of new medication, on developing related strategies by advertisers, and on training sales-reps, nationally, in the barriers to prescribing.
- Forming a meta-strategy for a health-focused ad agency. Am advertising agency hired me to crystallize its strategy and give it an extra oomph.
- Removing barriers to knowledge and action. From imaging results, which patients receive but have difficulty deciphering, to creating a scorecard that highlights what good health entails, I designed a deceptively simple, yet medically accurate tool that motivates people to improve health.
- Revolutionizing user Interface for a wellbeing company. How to go beyond measuring employees’ blood pressure and cholesterol level to actually informing individuals about their health status and motivating them to do something about this? In this consulting project, I helped a startup company redesign the user interface, increasing employee understanding and instilling ongoing motivation using an emotional tone and immediate feedback.
- Composing scientific white papers. How to convey academic knowledge in a clear, comprehensible way? Johnson and Johnson’s VP of Health Policy commissioned a white paper on non-communicable diseases, which also resulted in a scientific publication at the Journal of Health Communication. The work was presented at the 2011 UN Special Assembly on non-communicable diseases, and large international organizations have expressed an interest in adopting the tool globally.
- Training marketing executives and teams in consumer behavior. Consumer behavior, which Dr. Miron-Shatz taught at Wharton, remains at the core of how she views consumer interactions. She trained executives and teams from an international cellular brand in the secrets of the trade.
- Moderating advisory board meetings. Pharma advisory board meetings are filled with good intentions, knowledge, ego, and suspicion. Dr. Miron-Shatz is a master at navigating those. Her science skills, credibility, creativity, and unique training as a group counselor turn advisory board meetings into a productive experience, creating common ground, good will, and a true discussion of findings. One of the participants at a recent advisory board she led was cited as saying “the best advisory board meeting I ever attended.”
Working with me
If you would like to work with me, please get in touch via the contact page.